Form 4 Filing for Jean-Pierre Bizzari at ADC Therapeutics SA

Jean-Pierre Bizzari, a director at ADC Therapeutics SA, reported a series of transactions on June 1st and June 3rd, 2026. On June 1st, Bizzari was granted 45,000 restricted stock units (RSUs) under the company's 2019 Equity Incentive Plan. These RSUs vest on the earlier of one year from the grant date or the 2027 Annual Meeting of Shareholders, contingent upon continued service. Each RSU represents a contingent right to one share of common stock. On June 3rd, 12,600 shares were withheld by the Issuer to cover tax obligations related to the vesting of previously granted RSUs. Following these transactions, Bizzari's post-transaction share ownership stands at 139,302 shares. The transactions were filed on Form 4 and represent indirect ownership (D).